\n\n\n\n\t\t\n\t\t\tLuminous Medical\n\t\t\thttp://www.luminousmedical.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tLuminous Medical is developing an Automated Blood Glucose Monitor (ABGM) that addresses the rapidly growing clinical demand for better, safer glycemic control in the intensive care unit (ICU),...More»
\n\t\t\tLuminous Medical is developing an Automated Blood Glucose Monitor (ABGM) that addresses the rapidly growing clinical demand for better, safer glycemic control in the intensive care unit (ICU), Operating Room (OR) and Intermediate Care Units. Compelling clinical evidence has demonstrated significant morbidity and mortality benefits from normalizing glucose levels in hyperglycemic patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with time consuming and inadequate manual glucose monitoring methods.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tCarlsbad, CA, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tEmployees: 27
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tblood glucose,\n\t\t\t\tglycemic,\n\t\t\t\tglycemic control,\n\t\t\t\tautomated,\n\t\t\t\tglucose monitoring,\n\t\t\t\tglucose\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $23.5M (08/25/2008)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tAdams Street Partners, RiverVest Venture Partners, Finistere Ventures\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tGluMetrics,\n\t\t\t\t\t\tGlucoLight,\n\t\t\t\t\t\tVeraLight,\n\t\t\t\t\t\tVivoMedical,\n\t\t\t\t\t\tApex Biotechnology\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tGluMetrics,\n\t\t\t\t\tApex Biotechnology,\n\t\t\t\t\tCascade Metrix,\n\t\t\t\t\tGlucoLight\n\t\t\t\t
\n\t\t\t